Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension

This is a multicenter survey of Russian data on target heart rate achievement in patients with stable angina and arterial hypertension who are currently treated with beta-blockers for at least 2 months and with no dose change for a minimum of 4 weeks

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stable Angina Angina Pectoris Angina, Stable Cardiovascular Diseases Chest Pain Heart Diseases Hypertension Myocardial Ischemia Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Moscow, Russia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stable angina I-III class by the Canadian Cardiovascular Society Classification and concomitant primary hypertension
Subject is on beta-blockers treatment for at least 2 months prior to inclusion into survey, with no dose change for a minimum of 4 weeks

Exclusion criteria

Use of phenylalkylamine and benzothiazepine calcium channel blockers
Hemodynamic significant mitral and aortic valve disease
Acute myocardial infarction and unstable angina within 3 months before enrolment

Treatment and study plan

Primary outcomes

Establish the proportion of patients with stable angina and hypertension on beta-blockers reaching the resting HR goals according to ACC/AHA/ACP-ASIM* Guidelines

Time frame: 1 visit within 5 month

*American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Physicians (ACP-ASIM)

Secondary outcomes

Establish the mean dose of each beta-blocker in patients who achieved and not achieved resting HR goals

Time frame: 1 visit within 5 month
Compare quality of life in patients who achieved and non achieved resting HR goals

Time frame: 1 visit within 5 month
To estimate the correlation between achievement of resting HR goals according to ACC/AHA/ACP-ASIM Guidelines for the management of patients

Time frame: 1 visits within 5 month

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Observational Non-interventional Study - Epidemiological Survey "AchievemenT of Goal Resting HEart Rate on Beta-blockers in Patients With Stable angiNA and Hypertension in Routine Practice"

Acronym: Athena

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2011
First posted: Mar 23, 2011
Registry last updated: Jun 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed